跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Hepabig - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Hepabig
Approved
STANDARD
Hepabig
Green Cross Corporation
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
962a5de71a2eb8cd
Company
Green Cross Corporation
Type
Standard
Approval Details
Approval Id
962a5de71a2eb8cd
Drug Approval Philippines Name
Hepabig
Product Name
Hepabig
Registration Number
BR-307
Brand Name
Hepabig
Generic Name
Hepatitis B Immunoglobulin (Human)
Dosage Form
Solution For Injection
Dosage Strength
200 IU/mL
Manufacturer
Green Cross Corporation
Importer
Vizcarra Pharmaceutical, Inc.
Distributor
Vizcarra Pharmaceutical, Inc.
Company Detail Path
/organization/green-cross-corporation
Issuance Date
07 April 2022
Expiry Date
22 March 2027
Pharmacologic Category
Immunoglobulin
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
962a5de71a2eb8cd
Type
Standard
Back to Philippines FDA Approvals